Anika Therapeutics (ANIK) Cash from Investing Activities Growth (1y) (2011 - 2026)
Powered by 
Analysis
Anika Therapeutics (ANIK) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 0.00% |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | -137.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -137.48% |
| Mar 31, 2026 | -174.10% |
| Dec 31, 2025 | 115.15% |
| Sep 30, 2025 | 4.63% |
| Jun 30, 2025 | 84.16% |
| Mar 31, 2025 | 192.48% |
| Dec 31, 2024 | 28.97% |
| Sep 30, 2024 | -145.07% |
| Jun 30, 2024 | -133.56% |
| Mar 31, 2024 | -30.17% |
| Dec 31, 2023 | 27.24% |
| Sep 30, 2023 | 56.18% |
| Jun 30, 2023 | 24.90% |
| Mar 31, 2023 | -4.75% |
| Dec 31, 2022 | -103.95% |
| Sep 30, 2022 | -30.58% |
| Jun 30, 2022 | 16.27% |
| Mar 31, 2022 | -176.47% |
| Dec 31, 2021 | -107.38% |
| Sep 30, 2021 | -119.25% |